drugset / Trial / NCT04874129
Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate the safety and pharmacokinetics characteristics between YYC506 and concomitant administration of YYC506-T and YYC506-A
Timeline
- Start
- 2021-01-07
- Primary completion
- 2021-05-31
- Completion
- 2021-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YYC506 | Unknown | — | — |
| Subject | YYC506-A | Unknown | — | — |
| Subject | YYC506-T | Unknown | — | — |